Navigation Links
CellHealth Institute is Named 2013 Edison Award Winner
Date:5/9/2013

MONTCLAIR, N.J. (PRWEB) May 09, 2013

CellHealth™ Institute was voted a bronze winner for innovation at the Edison Awards. The event, celebrating 26 years of honoring the best in innovation and excellence in the development of new products and services, took place on April 25th event at Navy Pier in Chicago. Dr. Vincent Giampapa, CellHealth Institute’s founder and chief medical officer, joined hundreds of senior executives from some of the world’s most recognized companies to acknowledge the hard work and commitment of all of the 2013 Edison Award winners.

CellHealth Institute, a biotechnology company focused on cellular health that combines products and services with holistic lifestyle education, was awarded for its innovative health and wellness services. Dr. Vincent Giampapa also spoke about personalized cell health and CHI’s new cell health formula, everycell™, at the ‘Meet The Innovators’ Forum.

“We’re delighted that our innovations in cell health are gaining strong support in such illustrious circles,” said Dr. Vincent Giampapa.

“Our judges recognized CellHealth Institute as a true innovator out of the many products in health and wellness,” said Frank Bonafilia, executive director of the Edison Awards.

The ballot of nominees for the Edison Awards™ was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.

One of the evening’s many highlights was the presentation of the Edison Achievement Award to Dr. Paul E. Jacobs, chairman and CEO of Qualcomm Incorporated. The award honors innovation leaders and business executives who have made a significant and lasting contribution to innovation throughout their careers.

About CellHealth™ Institute
CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10716610.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches New Cell Health Formula
2. CellHealth Institute Launches with Support from Influential Investors
3. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
4. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
5. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
6. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
7. Stem Cell Institute Public Seminar on Adult Stem Cell Therapy in Miami, Florida May 11th, 2013
8. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
9. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
10. California Healthcare Institute Announces Executive Promotion
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):